Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

PRIDE complex side effects from EGFR inhibitors can be managed without stopping treatment.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

L-PGDS has specific binding sites for its functions and could help in drug delivery system design.

Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Persistent ED in Propecia users is not due to abnormal blood flow.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

The consensus provides guidelines for safely stopping danazol in hereditary angioedema treatment.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Dutasteride may help reduce brain inflammation and improve cognition.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

The estradiol valerate/dienogest oral contraceptive helps with heavy periods, may improve acne and symptoms in PCOS, and doesn't affect sexual function.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Dupilumab effectively improves skin conditions, reduces symptoms, and enhances quality of life in certain dermatological issues.